Papers
1
Total Citations
57
H-Index
1
About
Dr. Tony Hung is a leading voice in head and neck oncology, with a focused expertise in treatment deintensification for human papillomavirus (HPV)-associated oropharyngeal cancer (OPC). His seminal 2022 work, *Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‑associated oropharyngeal cancer* (57 citations), has become a cornerstone reference in the field. In this paper, Dr. Hung masterfully navigates the complex landscape of reducing aggressive chemoradiation regimens—which carry substantial long-term morbidities—for patients with favorable-prognosis HPV-positive OPC, a cancer whose incidence has been rising sharply in the United States. By synthesizing expert consensuses and highlighting ongoing controversies, he provides a critical roadmap for future clinical trials and practice. Dr. Hung’s contributions are shaping a paradigm shift toward personalized, less toxic therapies, directly improving quality of life for survivors. His work is essential reading for any researcher or clinician grappling with the challenge of balancing cure rates with treatment-related side effects in this growing patient population.
Research Focus
Key Achievements
Top Papers
- 1